What is it about?
Urocanate reductase (UrdA) is a bacterial enzyme that facilitates the production of imidazole propionate (ImP) and can be found in human gut microbiota. ImP has been linked to several human diseases, including type 2 diabetes. We have previously determined 3D molecular structures of the UrdA using cryogenic X-ray crystallography, which provided structural details of its active site and an insight into enzymatic mechanism. We showed how an important catalytic arginine residue is changing its position in the urocanate versus ImP bound states. In this study we further investigate the UrdA active site by using room-temperature X-ray crystallography. While both methods, cryogenic and room-temperature crystallography use protein crystals for X-ray data collection, applying cryogenic temperatures is known to sometimes mask structural features of the protein, which is in particular important when it comes to biological interpretations. The data collected at room-temperature in presence and absence of sulfate ions revealed more details in the dynamics of the catalytic arginine. Interestingly, we show that in this case the biologically relevant conformation of the arginine is easier captured in cryogenic crystal conditions. We further demonstrate that a sulfate or phosphate ion affects the position of the arginine and stabilizes it in the substrate like conformation.
Featured Image
Why is it important?
When human gut microbiota contains bacteria with UrdA activity resulting in increased levels of ImP this may contribute to the development of various health issues, such like type 2 diabetes and cardiovascular diseases. A possible therapeutic strategy would be to inhibit the bacterial UrdA by designing molecules binding to the enzyme and in this way blocking the production of ImP. Therefore, the detailed molecular studies of UrdA are necessary to enable drug design. Besides that, our study is relevant for the general use of X-ray crystallography as it demonstrates that the use of both X-ray data collection at cryogenic and room-temperatures is necessary in order not to miss structural details relevant for biological interpretations.
Perspectives
UrdA is not only an exciting enzyme in terms of its biology and being a drug target, but also because its truncated version can be routinely crystallized and allows for high quality X-ray data collection. Normally cryogenic crystallography is an easier choice that allows for crystal shipping, easier experiment planning and of course in many cases it is necessary to minimize radiation damage. However, as we work with UrdA daily and very close to a synchrotron facility, one day we thought it might be a good idea to test if we can collect X-ray data on our crystals at room-temperature. This worked great and the data analysis opened up new questions which then resulted in this study and newly discovered structural details of UrdA. It was exciting to see how a "let's try" experiment evolved into a focused study that provided new insights into UrdA.
Raminta Venskutonyte
Read the Original
This page is a summary of: Structural insights into urocanate reductase using room-temperature X-ray crystallography, Acta Crystallographica Section D Structural Biology, May 2026, International Union of Crystallography,
DOI: 10.1107/s2059798326003360.
You can read the full text:
Contributors
The following have contributed to this page







